Fate Therapeutics (FATE) – Analyst Comments
-
Fate Therapeutics (FATE) collapses 55% after terminating Janssen deal, earns several downgrades
-
Piper Sandler Downgrades Fate Therapeutics (FATE) to Neutral
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to FATE Stock Lookup